CAN FITE BIOPHARMA LTD-ADR (CANF)

US13471N3008 - ADR

2.22  -0.04 (-1.77%)

After market: 2.22 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-9-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
785.00K810.00K853.00K763.00K2.03M
Minority Interest Expense
N/AN/AN/AN/AN/A
Cost Of Goods
N/AN/AN/AN/A50.00K
Gross Profit
N/AN/AN/AN/A1.98M
Operating Expenses
10.23M10.91M13.70M14.90M14.04M
Research and Development
5.54M3.15M3.85M2.95M3.07M
Selling, General, and Administrative Expenses
4.69M7.75M9.85M11.95M10.97M
Operating Income
-9.44M-10.10M-12.84M-14.14M-12.01M
Interest Income/Expense
443.00K-61.00K245.00K82.00K-170.00K
Other Income/Expense
N/A-16.00K-18.00K-386.00K-448.00K
Non Recurring Items
N/AN/AN/AN/AN/A
Income Before Taxes
-9.00M-10.17M-12.62M-14.44M-12.63M
Income Tax
N/A0.000.000.000.00
Net Income
-9.00M-10.17M-15.21M-15.16M-12.63M
EBITDA
N/A-10.08M-12.83M-14.13M-11.99M
 
Per Share Data
EPS Diluted Total Ops
-2.07-2.53-5.57-8.57-29.78
Non GAAP EPS
N/AN/AN/AN/AN/A
 
Statistics
Gross Profit Margin
N/AN/AN/AN/A97.44%
Profit Margin
-1146.62%-1255.93%-1782.53%-1986.63%-621.31%
Operating Profit Margin
-1203.06%-1246.42%-1505.51%-1853.08%-590.90%

All data in USD

Charts